ArticleIranian journal of pharmaceutical research : IJPR2016

Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran.

Mina Golestani et al.PubMed ↗Full text ↗

No numbers read from the abstract.